课题基金 / 基金详情

项目摘要

项目成果

JOHN S. LAZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application proposes to establish a Molecular Libraries Screening Center (UP-MLSC) exploiting existing and new space and facilities at the University of Pittsburgh, with membership from the University of Pittsburgh, Carnegie Mellon University and Sandia National Laboratories. The overall objective of the UPMLSC will be to develop, implement, and optimize robust, optical methods for the detection, characterization, and refinement of small molecules with desired biological and pharmacological properties in cell-free, cell-based, and model organism-based assays assigned by the MLSCN Steering Group. The goals of the UPMLSC will be (a) to validate assays for use in high throughput screening, (b) to use these assays with secondary assays and informatics to identify active small molecules from chemical libraries, (c) to facilitate the use of these assays nationally, (d) to disseminate information about compound activity, and (e) to assist in the further optimization of the lead compounds. We intend to exploit and expand the documented existing interactive strengths of the Center members in assay implementation, high throughput and high content screening, combinatorial chemical synthesis, and informatics. We have carefully selected members for the UP-MLSC because of their expertise in the above-mentioned Core areas and in anticipation of potential assays that will be submitted to the Center. Moreover, we have recruited individuals who are expert in the design and development of novel fluorescent probes that may be useful in implementing new HTS assays, and individuals who have experience with assay development with Drosophila and zebrafish, which will be the models for organism-based assays in the UP-MLSC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10632154
  • 项目类别:
  • 资助金额:
    $0.65万
  • 财政年份:
    2022
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10330408
  • 项目类别:
  • 资助金额:
    $25.22万
  • 财政年份:
    2021
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10540550
  • 项目类别:
  • 资助金额:
    $5.5万
  • 财政年份:
    2021
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
Developing small molecule PTP4A3 inhibitors for ovarian cancer
  • 批准号:
    9769367
  • 项目类别:
  • 资助金额:
    $28.93万
  • 财政年份:
    2019
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
  • 批准号:
    2021JJ40433
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2021
  • 负责人:
    孙磊
  • 依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
  • 批准号:
    32001603
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    段真珍
  • 依托单位:
AREA国际经济模型的移植.改进和应用
  • 批准号:
    18870435
  • 项目类别:
    面上项目
  • 资助金额:
    2.0万元
  • 批准年份:
    1988
  • 负责人:
    史树中
  • 依托单位: